Cheap gout drug tested as COVID-19 treatment
NCT ID NCT06847204
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed trial tested whether colchicine, a cheap anti-inflammatory drug used for gout, can help patients with mild to moderate COVID-19 pneumonia. Sixty-six patients in Lahore were given the drug to see if it shortens hospital stays and reduces oxygen needs. The goal is to find an affordable treatment option for developing countries.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Colchicine (an anti-inflammatory drug, commonly used for gout)
What this could lead to
If it works, this could point toward an affordable treatment option for COVID-19 pneumonia in developing countries.
What could go wrong
This is a small, early-phase trial (Phase 1/2) with only 66 participants, so results may not be conclusive or apply to all patients. Colchicine also has known side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General hospital
Lahore, Punjab Province, Pakistan